Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
N-Butyl-deoxynojirimycin (NB-DNJ) has been approved for clinical trials as a potential therapy for Gaucher disease, a glycolipid lysosomal storage disorder. As this compound has both glycoprotein processing α-glucosidase and ceramide glucosyltransferase inhibitory activity, we have sought to determi...
Κύριοι συγγραφείς: | Butters, T, van den Broek, L, Fleet, G, Krulle, T, Wormald, M, Dwek, R, Platt, F |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2000
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
ανά: Boomkamp, S, κ.ά.
Έκδοση: (2010) -
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
ανά: Mellor, H, κ.ά.
Έκδοση: (2003) -
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
ανά: Butters, T, κ.ά.
Έκδοση: (2000) -
Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
ανά: Butters, T, κ.ά.
Έκδοση: (2005) -
Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.
ανά: van der Spoel, A, κ.ά.
Έκδοση: (2008)